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582a Wednesday, February 11, 2015(M: 1652%, n¼6; F: 1352%, n¼15). BayK(-) increased flavoprotein
oxidation in mdx cardiomyocytes from animals treated with a single weekly
dose (M:1353%, n¼13; F: 1053%, n¼9) and with multiple doses per
week (M: 1752%, n¼16; F: 1452, n¼24). These data indicate that either
single or multiple i.p. injections per week of morpholino oligo peptides are
effective at restoring cardiac mitochondrial function in both male and female
mdx mice.
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Endolysosomal organelles play a key role in trafficking, breakdown and
receptor-mediated recycling of different macromolecules such as low-
density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or
transferrin. In the liver, receptor-mediated uptake of low-density lipoproteins
(LDLs) and subsequent intracellular transport is essential for hepatic choles-
terol homoeostasis and plasma lipoprotein metabolism. Dysfunction within
this pathway results in liver disease such as non-alcoholic fatty liver disease
(NAFLD), which is associated with increased cardiovascular and liver-
related mortality. It has been estimated that as many as 30% of adults
in these countries have NAFLD. This liver disease has thus emerged as a
substantial public health concern. Here, we examine the role of two-pore
channel (TPC) 2, an endolysosomal cation channel, in these processes.
Embryonic mouse fibroblasts were generated from wild type and TPC2 defi-
cient mice and characterized by single lysosome patch clamp employing
conventional patch clamp as well as planar patch clamp. In addition, traf-
ficking assays were performed. Embryonic mouse fibroblasts and hepato-
cytes lacking TPC2 display a profound impairment of LDL-cholesterol
and EGF/EGF-receptor trafficking. Mechanistically, both defects can be
attributed to a dysfunction of the endolysosomal degradation pathway
most likely on the level of late endosome to lysosome fusion. Importantly,
endolysosomal acidification or lysosomal enzyme function are normal in
TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic
cholesterol overload and liver damage consistent with non-alcoholic
fatty liver hepatitis. These findings indicate reduced metabolic reserve of
hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial
role in trafficking in the endolysosomal degradation pathway and, thus, is
potentially involved in the homoeostatic control of many macromolecules
and cell metabolites.
Ion Channels, Pharmacology, and Disease
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Coronaviruses (CoV) are vertebrate pathogens that cause common colds, bron-
chiolitis and acute respiratory distress syndrome. In fact, their relevance
increased when the causative agent of the severe acute respiratory syndrome
(SARS) was identified as a CoV. CoV E protein is a small transmembrane pro-
tein of between 76-109 amino acids in length that modulates coronavirus
morphogenesis, tropism and virulence [1].
We sought to elucidate the role of E protein IC activity in virus pathogenesis
by combining our knowledge of residues essential for E protein ion conduc-
tivity with the manipulation of SARS-CoV genome. To test the contribution
of E protein IC activity in virus pathogenesis, two recombinant mouse-
adapted SARS CoVs, each containing one single amino acid mutation that
suppressed ion conductivity, were engineered. After serial infections, mutant
viruses, in general, incorporated compensatory mutations within E gene
that rendered active ion channels. Furthermore, IC activity conferred better
fitness in competition assays, suggesting that ion conductivity represents an
advantage for the virus. Interestingly, mice infected with viruses displaying
E protein IC activity, either with the wild-type E protein sequence or withthe revertants that restored ion transport, rapidly lost weight and died. In
contrast, mice infected with mutants lacking IC activity, which did not incor-
porate mutations within E gene during the experiment, recovered from disease
and most survived.
We have shown that SARS-CoV E protein IC activity is a virulence
determinant.
[1] DeDiego, M.L., et al 2008. Virology 376, 379-389.
[2] Verdia´-Ba´guena C., et al. 2012. Virology. 432: 485-494.
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Influenza A virus (IAV) exhibits a high mutation frequency. Mutations in the
proton channel M2 have created substantial IAV drug resistance to previously
effective drugs, such as amantadine (AMT), along with its analogs. The main
drug-resistant variation in the M2 proton channel, which has become ubiqui-
tous in humans, is the mutation S31N. Divalent copper has previously been
shown, using in vitro assays involving SSNMR and Xenopus oocytes, to bind
and block wild type M2 at the His37 selectivity filter. Here we report initial
tests of the hypothesis that, given the essential, conserved nature of the selec-
tivity filter, a complex consisting of copper bound to an amantadine derivative
might serve as a broad-spectrum anti-IAV drug. The EC50 of AMT, two AMT
analogs, CuCl22H2O, and four previously published Cu2þ complexes were
tested for antiviral activity against the California/07/2009 (H1N1) IAV strain
containing the S31N M2 proton channel in viral mini-plaque assays and for
M2(22-62, S31N)-mediated proton transport block in liposomes. A novel,
AMT-based divalent copper compound, NAG 107, emerged as a plausible
lead with an EC50 of 2.91 5 0.29 mM in the viral mini-plaque assay and
4.5 5 0.6 mM in the liposome assay, 21-fold and 11-fold better than amanta-
dine in these assays, respectively.
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Drug-induced block of ‘Human ether-a-go-go-related Gene’ (hERG) Kþ chan-
nels is the main reason of long QT syndrome, a disorder of cardiac repolariza-
tion which may lead to sudden death due to ventricular fibrillation. This side
effect has been the most frequent cause for drug withdrawal from the pharma-
ceutical market. For this reason, understanding the molecular determinants of
hERG channel inhibition is an interesting strategy to avoid the cardiotoxicity
of drugs.
Lubeluzole, a neuroprotective compound, has been associated with the
acquired long QT syndrome and ventricular arrhythmias; however its effects
on the hERG Kþ channel have not been described to date. Thus, the molecular
determinants for lubeluzole action on hERG channel were studied using the
patch clamp technique. We found that lubeluzole and its enantiomer are highly
potent inhibitors of hERG current with an IC50 value of around 10 nM
(no stereoselectivity observed). Moreover we observed that hERG inhibition
by lubeluzole is time- and voltage-dependent. In fact lubeluzole causes a nega-
tive shift in the voltage dependence of hERG current activation and accelerates
tail current deactivation, suggesting that it preferentially blocks the activated
state of the channel.
To go further in details, we synthesized a series of lubeluzole congeners
designed to explore the role of lipophilicity and electronic distribution.
Structural variations were designed on the basis of the indications gained by
quantum-mechanical calculations run at several DFT levels.
For each compound we determined the relative hERG affinity and the state-
dependent mechanism, to evaluate how specific modification of drug structure
affected hERG binding interaction. Main SAR results will be presented.
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Rosetta Modeling Method
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Calcium-activated potassium channels, including the intermediate-conduc-
tance KCa3.1 channel and the related small-conductance KCa2 channels,
Wednesday, February 11, 2015 583amonitor and regulate intracellular calcium and are ideal pharmacological
targets for immunosuppression, fibroproliferative disorders, hypertension and
various neurological diseases. However, the development of drugs specifically
for these medically relevant channels faces serious challenges because there is
no available crystal structure that could be used for structure-assisted drug
design. We used the Kv1.2-Kv2.1 channel structure (pdb id: 2R9R) as a tem-
plate to generate a homology model of the KCa3.1 channel transmembrane
region using the Rosetta modeling method. Docking of small molecules that
are known to block KCa3.1 channel currents using Rosetta generated structural
models of channel - drug complexes that can be validated using experimental
approaches. Here we report the validation of the binding sites for the dihydro-
pyridine nifedipine predicted by Rosetta’s lowest energy stimulation of the
KCa3.1 channel complex. We used a combination of site-directed mutagenesis
and electrophysiological patch-clamp recording to test the identified amino
acid residues located between the pore lining S5 and S6 segment. Blocking
of the KCa3.1 channel by nifedipine was reduced by altering the side chains
at positions L209, T212 and V278 to either alanine or valine, with T212 the
most affected residue. Bulkier side-chain change to phenylalanine confirmed
T212 as the main interacting site for nifedipine without compromising the
channel’s affinity for TRAM-34. Thus, by correctly identified the interaction
of the dihydropyridine nifedipine with the KCa3.1 channel complex, Rosetta
models can be used to understand the molecular mechanism of action of
KCa channel blockers and gating modulators and assist with drug design
efforts.
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GBR-12909 (vanoxerine) is a potent highly selective dopamine transporter
antagonist. It was initially developed for treatment of Parkinson’s disease
and while safe in man, lacked efficacy. Although a potent hERG blocker,
the drug exhibits multiple ion channel effects including frequency-
dependence. The drug effectively terminated induced, sustained atrial fibril-
lation (AF) and atrial flutter in a canine model of sterile pericarditis.
Subsequently the drug terminated AF in a Phase 2B ascending dose trial. Pre-
vious in vitromeasurements used protocols that did not address the issue of the
late Nav1.5 current which is important in understanding safety of a potent
hERG blocker.
Peak and late sodium currents were measured in HEK-293 cells stably ex-
pressing the human Nav1.5 channel. Peak currents were measured using a
step-ramp protocol consisting of a 40 ms step to 15 mV (where the peak
current was measured), a 180 ms step to þ30 mV and a 200 ms ramp to
the holding potential of 80 mV (1 Hz stimulating frequency). The effect
of the drug was parameterized with a single binding isotherm having an
IC50 of 29 5 3 nM (95% CI: 22-37) and a Hill coefficient of 0.91 5 0.10
(95% CI: 0.68-1.18) (seven cells, three concentrations). We also evaluated
the effect of GBR-19209 on currents increased using the sea-anemone toxin
ATX-II as a surrogate of the late sodium current. The calculated IC50 and
Hill coefficients from five cells and five concentrations were 93 5 9 nM
(95% CI: 7-117) and 1.57 5 0.24 (95% CI: 1.05-2.67), respectively. Thus,
GBR-12909 block is at least sixty times more potent than ranolazine’s
(IC50 ¼ 6 mM).The combination of potent peak and late sodium block may
explain the antiarrhythmic and safe profile of the drug.
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Understanding how small molecules potentiate CFTR gating is critical for
developing novel therapy for cystic fibrosis. Our previous studies have sug-
gested that VX-770 (ivacaftor), a CFTR potentiator now used in clinics,
increases the Po of CFTR by shifting the gating conformational changes in
CFTR’s transmembrane domains (TMDs) to favor the open channel configura-
tion. Lately, another CFTR potentiator NPPB was reported to enhance CFTR
activity through a modus operandi that exploits the ATP hydrolysis-driven,
non-equilibrium gating mechanism unique to CFTR. It is however puzzling
that NPPB can also increase the activity of non-hydrolytic G551D-CFTR,
the third most common pathogenic mutation. We therefore set forth to unravel
the mechanism of NPPB using VX-770 as a reference. Once the blocking effect
of NPPB was corrected, we found that NPPB and VX-770, when applied alone,
increased the Po of G551D-CFTR by 6.95 0.8 (n ¼ 12) and 9.35 1.4 (n ¼21) folds respectively. Once these two reagents were applied together, how-
ever, the Po was increased by 28.985 7.6 fold (n¼ 10), less than the expected
magnitude (~ 60-fold) if NPPB and VX-770 work independently. Hence, NPPB
only increases the Po of G551D-CFTR by 3.75 0.4 fold (n ¼ 9) in the pres-
ence of VX-770. Similarly, a much reduced enhancement (4.85 1.8 fold, n ¼
5) of the Po by VX-770 in the presence of NPPB was seen. Interestingly, we
also observed that VX-770 effectively potentiates a CFTR mutant with its sec-
ond nucleotide-binding domain completely removed (i.e., dNBD2), whereas
NPPB has virtually no effect (n ¼ 12). These results can be explained by a
gating model featuring an energetic coupling between opening/closing of the
gate in TMDs where VX-770 binds and dimerization/dissociation of NBDs
where NPPB acts on.
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‘‘Use-’’ or ‘‘state-’’ dependent block of voltage-gated sodium channels is
characteristic of therapeutic agents used to moderate electrical activity in path-
ologically hyperactive tissues and combat certain forms of epilepsy, cardiac
arrhythmia, myotonia, and pain. Externally acting Na channel pore blockers
are not commonly used as therapeutic drugs, but intraperitoneal m-conotoxin
(mCTX) KIIIA can act as an effective analgesic against inflammatory pain in
mice, at concentrations that do not cause obvious systemic side effects (Zhang
et al 2007 J Biol Chem 42:30699). This action appears to result from highly
specific targeting to neuronal Na channels, without essential reliance on the
use-dependent potency that contributes to the efficacy of clinical local anes-
thetics. mCTXs, although highly selective among closely related eukaryotic
Na channels, have recently been found to block bacterial Nav channels with
high affinity (Chen & Chung 2012 Biophys J 102:483; Finol-Urdaneta et al
2013 Biophys J 104:136a). In addition, the block was potentiated at more de-
polarized holding potentials. Here, we explore the dependence of mCTX PIIIA
block of NaChBac and NavSp1 on varying patterns of conditioning depolari-
zation. Briefly, in the low picomolar range, PIIIA application was associated
with faster inactivation decay during a test depolarization, and block of the
peak current. The speeding of inactivation precedes the block of current
following PIIIA application, and this kinetic effect was obvious at more nega-
tive holding potentials than was the decrease in peak current. In NaChBac, both
activation and inactivation were shifted in the hyperpolarizing direction by
~25-30 mV in the presence of 5pM PIIIA. The data suggest that PIIIA binding
is conformation dependent, with high affinity for non-conducting, depolariza-
tion-induced states. At present, the relative importance of ‘‘pre-activated’’
and ‘‘in-activated’’ states in potentiating inhibition by PIIIA is unclear.
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Sodium absorption in epithelial cells is rate-limited by the epithelial sodium
channel (ENaC) activity in lungs, kidney and the distal colon. Pathophysiolog-
ical conditions, such as cystic fibrosis and Liddle syndrome, result from water-
electrolyte imbalance partly due to malfunction of ENaC’s molecular regu-
lation. The molecular mechanism(s) of pathologically implicated mutations
in ENaC subunits are largely unknown due to absence of structural models
for ENaC’s oligomers. Here, we propose a dynamics-driven mechanism of
the gain of function mutation aW493R implicated in atypical cystic fibrosis.
We utilize a combination of discrete molecular dynamics simulations (DMD)
of the extracellular region of ENaC’s heterotrimer abg and functional data
from whole-cell electrophysiology experiments. Structure-function studies
suggest that tetramers and trimers are the major characterized functional olig-
omeric states of ENaC. Using the crystal structure of the acid sensing ion chan-
nel, ENaC’s structural homolog in the ENaC/degenerin mechanosensitive
ion channel family, we have constructed homology models of ENaC subunits
alpha, beta and gamma, in addition to the heterotrimers abg, agb and the
heterotetramer abag. Electrophysiology data show constitutive activity of
aW493Rbg in oocytes indicated by higher open probability and elevated basal
activity compared to WT. Our DMD simulation provides an allosteric frame-
work, which agrees with experimental data. W493R rewires the electrostati-
cally mediated inter-residue interaction network in close proximity to W493,
resulting in widening of the pore geometry in the outer mouth of the pore in
